Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
ICH Q1A(R2): Stability Testing of New Drug Substances and Products
Research design and methods This study was approved by the Institutional Review Board of National Cheng Kung University (A-EX-106-013)
reports institutional contracts with Amgen, Applied Therapeutics, AstraZeneca, Biomea, Boehringer Ingelheim, Corcept, Eli Lilly, Fractyl, Kailera, Novo Nordisk, Pfizer, Recordati, Rhythm and Servier, and a consultant role at Baim Institute for Clinical Research, Mediflix, Sanofi and Roche
Brozinick, J
Walle A, Andreeff M , Clarkson BD
:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)
US$ 22.10
US$ 21.53
US$ 28.51
US$ 20.19
